Last reviewed: June 26, 2026

Last updated: June 26, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is one of the most studied weight loss medications available, with clinical trials demonstrating significant and sustained results. In the landmark STEP trials, patients taking semaglutide lost between 15% and 22% of their starting body weight—more than three times the loss seen with diet and exercise alone. Success depends on how your body responds to GLP-1 signaling, which is where personalized dosing and genetic insights make a real difference.

Start your GLP-1 program with PlexusDx

One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.

Start your intake →

What Semaglutide Does to Your Body and Appetite

Semaglutide mimics glucagon-like peptide-1 (GLP-1), a natural hormone that controls hunger and blood sugar. When you take semaglutide, it binds to GLP-1 receptors in your brain's appetite center, signaling fullness faster and lasting longer after meals. This dual action—reduced hunger plus delayed stomach emptying—creates a powerful metabolic shift that makes eating less feel natural rather than forced.

Beyond appetite suppression, semaglutide slows how quickly food moves through your digestive tract, which extends the feeling of satisfaction. It also improves how your body uses insulin, helping stabilize energy levels and reduce cravings for refined carbohydrates. Most patients report that food becomes less psychologically rewarding, meaning the constant mental pull toward snacking or emotional eating diminishes significantly within the first few weeks.

Clinical Trial Results: Real Weight Loss Numbers

The STEP (Semaglutide Treatment Effect in People with obesity) trials followed over 4,500 patients and remain the gold standard for semaglutide evidence. Patients receiving the highest dose (2.4 mg weekly) lost an average of 15.3 kg (roughly 22% of body weight) compared to 2.6 kg in the placebo group over 68 weeks. Even at lower doses, results were substantial: the 1.7 mg dose produced approximately 17% weight loss, showing that meaningful outcomes occur across the dosing range.

Long-term follow-up data suggests these results are largely sustained for patients who continue treatment. When participants stopped semaglutide, weight returned gradually, indicating that the medication must be maintained to preserve loss. This finding highlights the importance of personalized treatment plans rather than short-term "quick fix" approaches to weight management.

How Genetics Influence Your Semaglutide Response

The PlexusDx Precision Peptide Genetic Test analyzes FTO and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Semaglutide Cost and Access Without Insurance

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan across three commitment tiers, with no insurance required and no membership fees. Because PlexusDx sources from licensed 503A compounding pharmacies, patients access pharmaceutical-grade medication at a fraction of brand-name prices while maintaining full safety and sterility standards. Each prescription is prepared individually in a state-licensed facility, ensuring purity and potency.

Your dose may need to go up as your body adapts to treatment, but your price won't—PlexusDx maintains flat monthly pricing regardless of dose level. HSA and FSA accounts are eligible, and the Precision Peptide Genetic Test is available for $298, helping refine your protocol based on your genetic profile. PlexusDx serves all 50 states and handles the entire process online, from initial consultation through home delivery of your medication.

Common Side Effects and How to Manage Them

Nausea is the most frequently reported side effect, especially during the first 1–2 weeks and when doses increase, but typically subsides within days to weeks as your body adjusts. Mild gastric upset, reduced appetite (which is therapeutic), and occasional constipation or loose stools occur in 20–30% of patients, most often early in treatment. These effects are generally mild-to-moderate and manageable with dietary adjustments, hydration, and time; severe side effects are rare and usually prompt dose adjustment or brief treatment pausing.

Individual tolerance varies widely based on genetics, baseline metabolism, and how quickly doses are escalated. Starting at a low dose and increasing gradually—typically every week or two—allows your system to adapt without overwhelming your digestive tract. If side effects become uncomfortable, your PlexusDx provider can adjust your escalation schedule or switch to oral semaglutide, which some patients tolerate better despite higher out-of-pocket cost.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How fast will I see weight loss results with semaglutide?

Most patients notice reduced appetite within days, but measurable weight loss typically appears within 2–4 weeks as your calorie deficit accumulates. By week 12, average loss is 3–5% of starting body weight, with trajectory accelerating as your dose reaches therapeutic levels. Peak results appear around 4–6 months of consistent treatment.

Can I take semaglutide if I have diabetes or only for weight loss?

Semaglutide works for both weight management and blood sugar control, though PlexusDx specializes in personalized weight loss protocols. If you have diabetes or prediabetes, your healthcare provider should coordinate your semaglutide therapy to monitor glucose response and adjust other medications as needed. The metabolic benefits—improved insulin sensitivity and stable blood sugar—often amplify weight loss results.

What's the difference between PlexusDx compounded semaglutide and brand-name Ozempic?

Both contain the same active pharmaceutical ingredient (semaglutide), but PlexusDx sources from licensed 503A compounding pharmacies, which prepare individual prescriptions under strict pharmaceutical standards. The key difference is cost: compounded semaglutide is $189/mo month-to-monthnth versus several hundred dollars for brand-name, making personalized weight loss therapy accessible without insurance. Efficacy and safety profiles are equivalent.

What happens to my weight after I stop semaglutide?

Clinical data shows weight gradually returns over months if treatment stops, though loss is usually slower than initial gain because your metabolism and eating patterns have shifted. Maintaining weight loss long-term typically requires either continued semaglutide therapy or a structured lifestyle program that reinforces the habits you've built during treatment. Many patients use maintenance doses—lower than active-loss doses—to preserve results indefinitely.

How does the Precision Peptide Genetic Test improve my semaglutide results?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves